Skip to content

The research of serum biomarker characteristics in postherpetic neuralgia-related proteins

The research of serum biomarker characteristics in postherpetic neuralgia-related proteins

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026021
Enrollment
Unknown
Registered
2019-09-18
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Gold Standard:PHN Chinese Expert Consensus: somatic pain
hyperalgesia, such as touch pain
pain site along nerve distribution
blisters in the pain area.
in&#32
sersum&#32
of&#32
patients&#32
with&#32
PHN&#32
based&#32
on&#32
Protein&#32
technique.

Sponsors

Tianjin First Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 50 to 75 years; 2. The clinical diagnosis of patients is clear; 3. The patients in the acute stage of herpes zoster are not more than 7 days away from the onset of the disease; 4. When patients with post-herpes zoster neuralgia are treated, the pain lasting time after herpes healing lasts more than 90 days.

Exclusion criteria

Exclusion criteria: 1. Organic diseases such as heart and lung; 2. Severe cognitive impairment; 3. Recent use of hormones or immunosuppressive agents; 4. Malignant tumors and other immune system diseases; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
biomarker;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactHe Yongjin

Tianjin First Center Hospital

heyongjin1995@sina.com+86 13502096026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026